Molecular Modeling for Structural Insights Concerning the Activation Mechanisms of F1174L and R1275Q Mutations on Anaplastic Lymphoma Kinase

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Cheng-Han JiangChia-Ning Yang

Abstract

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in various cancers. In its basal state, the structure of ALK is in an autoinhibitory form stabilized by its A-loop, which runs from the N-lobe to the C-lobe of the kinase. Specifically, the A-loop adopts an inhibitory pose with its proximal A-loop helix (αAL-helix) to anchor the αC-helix orientation in an inactive form in the N-lobe; the distal portion of the A-loop is packed against the C-lobe to block the peptide substrate from binding. Upon phosphorylation of the first A-loop tyrosine (Y1278), the αAL-helix unfolds; the distal A-loop detaches from the C-lobe and reveals the P+1 pocket that accommodates the residues immediately after their phosphorylation, and ALK is activated accordingly. Recently, two neuroblastoma mutants, F1174L and R1275Q, have been determined to cause ALK activation without phosphorylation on Y1278. Notably, F1174 is located on the C-terminus of the αC-helix and away from the A-loop, whereas R1275 sits on the αAL-helix. In this molecular modeling study, we investigated the structural impacts of F1174L and R1275Q that lead to the gain-of-function event. Wild-type ALK and ALK with phosphorylated Y1278 were also modeled for comparison....Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S E ShoelsonM F White
Mar 30, 2001·The Journal of Biological Chemistry·G E StoicaA Wellstein
Jul 18, 2002·The Journal of Biological Chemistry·Gerald E StoicaAnton Wellstein
Nov 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alexandr P KornevLynn F Ten Eyck
Dec 12, 2007·The Journal of Biological Chemistry·Carmen J TartariCarlo Gambacorti-Passerini
Oct 17, 2008·Nature·Yuyan ChenSeishi Ogawa
Jun 3, 2009·BMC Bioinformatics·Vincent Le GuillouxPierre Tuffery
Nov 3, 2009·Biochimica Et Biophysica Acta·Alexandr P Kornev, Susan S Taylor
Jul 17, 2010·The Biochemical Journal·Christian C LeeGlen Spraggon
Oct 26, 2010·Trends in Biochemical Sciences·Susan S Taylor, Alexandr P Kornev
Nov 11, 2011·Science Translational Medicine·Scott C BreslerYaël P Mossé
May 10, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Dec 1, 2012·Drug Discovery Today·Lorenzo Palmieri, Giulio Rastelli
Dec 4, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Robert Roskoski
Mar 29, 2013·Biochimica Et Biophysica Acta·Susan S TaylorAlexandr P Kornev
Sep 26, 2013·Nature Reviews. Cancer·Bengt Hallberg, Ruth H Palmer

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

LEaP
AMBER
fpocket

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Gudrun SchleiermacherTommy Martinsson
Journal of Cellular and Molecular Medicine
Wei WangXuedong Liu
© 2022 Meta ULC. All rights reserved